Literature DB >> 24799973

Acute gout episodes during treatment with capecitabine: a case report.

Renata D'Alpino Peixoto1, Rachel Cossetti1, Howard Lim1, Winson Y Cheung1, Hagen Kennecke1.   

Abstract

Entities:  

Year:  2014        PMID： 24799973      PMCID： PMC4007678     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced gout.

Authors:  J T Scott
Journal:  Baillieres Clin Rheumatol       Date:  1991-04

Review 2.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

3.  Acute gout during treatment with paclitaxel for metastatic melanoma.

Authors:  Doru T Alexandrescu; Thomas E Ichim; Filamer Kabigting; Constantin A Dasanu
Journal:  Rheumatology (Oxford)       Date:  2009-05-20       Impact factor: 7.580

4.  Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Authors:  E Van Cutsem; C Twelves; J Cassidy; D Allman; E Bajetta; M Boyer; R Bugat; M Findlay; S Frings; M Jahn; J McKendrick; B Osterwalder; G Perez-Manga; R Rosso; P Rougier; W H Schmiegel; J F Seitz; P Thompson; J M Vieitez; C Weitzel; P Harper
Journal:  J Clin Oncol       Date:  2001-11-01       Impact factor: 44.544

5.  Gemcitabine-induced gouty arthritis attacks.

Authors:  Sal Bottiglieri; Neil Tierson; Raina Patel; Jae-Hyun Mo; Syed Mehdi
Journal:  J Oncol Pharm Pract       Date:  2012-11-20       Impact factor: 1.809

6.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.

Authors:  Yanyan Zhu; Bhavik J Pandya; Hyon K Choi
Journal:  Arthritis Rheum       Date:  2011-10

7.  Increased risk of cancer among gout patients: a nationwide population study.

Authors:  Chang-Fu Kuo; Shue-Fen Luo; Lai-Chu See; I-Jun Chou; Yao-Fan Fang; Kuang-Hui Yu
Journal:  Joint Bone Spine       Date:  2011-11-15       Impact factor: 4.929

8.  Capecitabine as adjuvant treatment for stage III colon cancer.

Authors:  Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

9.  Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression.

Authors:  Xiulong Xu; Geetha S Rao; Veronika Groh; Thomas Spies; Paolo Gattuso; Howard L Kaufman; Janet Plate; Richard A Prinz
Journal:  BMC Cancer       Date:  2011-05-23       Impact factor: 4.430
  9 in total
  1 in total

Review 1.  Mechanisms of chemotherapy-induced behavioral toxicities.

Authors:  Elisabeth G Vichaya; Gabriel S Chiu; Karen Krukowski; Tamara E Lacourt; Annemieke Kavelaars; Robert Dantzer; Cobi J Heijnen; Adam K Walker
Journal:  Front Neurosci       Date:  2015-04-21       Impact factor: 4.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.